School personnel information


Shirakami Yoshifumi


nuclear medicine, radiopharmaceuticals, PET, SPECT, theranostics

Mail Address

Mail Address

Laboratory Phone number





Organization 【 display / non-display

  • 2015.06.01 - 2019.03.31, Division of Medicine, Graduate School of Medicine, Associate Professor

  • 2019.04.01 - , Institute for Radiation Sciences, Associate Professor

Education 【 display / non-display

Tohoku University Graduate School, Division of Natural Science  Completed 1984.03

Employment Record 【 display / non-display

Associate Officer, Research Center Nihon Medi-Physics Co.,Ltd. 1984.04 - 2015.05

Academic Society Membership 【 display / non-display

  • Society of Japanese Nuclear Medicine


Academic Papers 【 display / non-display

  • Theranostics targeting fibroblast activation protein in the tumor stroma: (64)Cu and (225)Ac labelled FAPI-04 in pancreatic cancer xenograft mouse models., Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K, Toyoshima A, Nagata K, Shimosegawa E, Haberkorn U, Kratochwil C, Shinohara A, Giesel F, Hatazawa J., Journal of Nuclear Medicine,2019 Oct 4, 2019.10, Papers

  • Enhancement of astatine-211 uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer., Watabe T, Kaneda-Nakashima K, Liu Y, Shirakami Y, Ooe K, Toyoshima A, Shimosegawa E, Fukuda M, Shinohara A, Hatazawa J., Journal of Nuclear Medicine, 2019.02, Papers

  • Radiolabeling of small molecules with astatine (211At) for theranostics, Yoshifumi Shirakami, International Workshop on the Biological Effects of Radiation (BER2018),定期刊行物の発行予定なし。抄録集は下記URLに掲載あり:, 2018.03, International Conference(Proceedings)

  • A new method for the preparation of astatine-211(211At) and iodine-123(123I) labelled amino acid analogues of phenylalanine, 211At-Phe and 123I-Phe, for radionuclide therapy and SPECT imaging applications, Y. Shirakami, H. Ikeda, J. Hatazawa, European Journal of Nuclear Medicine and Molecular Imaging,2017; 44(Supple2):S536-7, 2017.10, International Conference(Proceedings)

  • Energy Failure Hypothesis for Takotsubo Cardiomyopathy, Hirano K, Shimizu K, Ikeda Y, Shirakami Y, Nagasaka H., Annals of Nuclear Cardiology ,3:105-109, 2017.08, Papers

display all >>